Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of M72/AS01E TB Vaccine in HIV-positive Adults
NCT00707967Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2008
- Primary completion
- May 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of M72 + AS01E in Tuberculosis (TB), sponsored by GSK. Started Jun 2008; status: completed.
02
Drugs
M72 + AS01E
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00707967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00707967.